Dvořáčková, E.; Šíma, M.; Petrus, J.; Klapková, E.; Hubáček, P.; Pozniak, J.; Havlín, J.; Lischke, R.; Slanař, O.
Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients. Pharmaceutics 2022, 14, 408.
https://doi.org/10.3390/pharmaceutics14020408
AMA Style
Dvořáčková E, Šíma M, Petrus J, Klapková E, Hubáček P, Pozniak J, Havlín J, Lischke R, Slanař O.
Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients. Pharmaceutics. 2022; 14(2):408.
https://doi.org/10.3390/pharmaceutics14020408
Chicago/Turabian Style
Dvořáčková, Eliška, Martin Šíma, Jakub Petrus, Eva Klapková, Petr Hubáček, Jiří Pozniak, Jan Havlín, Robert Lischke, and Ondřej Slanař.
2022. "Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients" Pharmaceutics 14, no. 2: 408.
https://doi.org/10.3390/pharmaceutics14020408
APA Style
Dvořáčková, E., Šíma, M., Petrus, J., Klapková, E., Hubáček, P., Pozniak, J., Havlín, J., Lischke, R., & Slanař, O.
(2022). Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients. Pharmaceutics, 14(2), 408.
https://doi.org/10.3390/pharmaceutics14020408